BR112022009664A2 - Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos - Google Patents

Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos

Info

Publication number
BR112022009664A2
BR112022009664A2 BR112022009664A BR112022009664A BR112022009664A2 BR 112022009664 A2 BR112022009664 A2 BR 112022009664A2 BR 112022009664 A BR112022009664 A BR 112022009664A BR 112022009664 A BR112022009664 A BR 112022009664A BR 112022009664 A2 BR112022009664 A2 BR 112022009664A2
Authority
BR
Brazil
Prior art keywords
drug
methods
distribution
managing
systems
Prior art date
Application number
BR112022009664A
Other languages
English (en)
Portuguese (pt)
Inventor
Dana Adrian
Adelman Daniel
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR112022009664A2 publication Critical patent/BR112022009664A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112022009664A 2019-11-20 2020-11-19 Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos BR112022009664A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962938180P 2019-11-20 2019-11-20
US202063056492P 2020-07-24 2020-07-24
PCT/US2020/061362 WO2021102186A1 (en) 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug

Publications (1)

Publication Number Publication Date
BR112022009664A2 true BR112022009664A2 (pt) 2022-08-16

Family

ID=75909665

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022009664A BR112022009664A2 (pt) 2019-11-20 2020-11-19 Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos

Country Status (8)

Country Link
US (2) US20220415464A1 (https=)
EP (1) EP4061753A4 (https=)
JP (1) JP2023502423A (https=)
CN (1) CN114981191B (https=)
AU (1) AU2020388398A1 (https=)
BR (1) BR112022009664A2 (https=)
CA (1) CA3162233A1 (https=)
WO (1) WO2021102186A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022003604A1 (en) 2020-07-01 2022-01-06 Société des Produits Nestlé S. A. Determining medical staffing for oral immunotherapy
US12100510B2 (en) 2022-10-10 2024-09-24 CareMetx, LLC System and method for enrollment into patient service programs

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797515A (en) * 1995-10-18 1998-08-25 Adds, Inc. Method for controlling a drug dispensing system
US20090019552A1 (en) * 2000-03-15 2009-01-15 Mclaughlin Mark R Healthcare Medical Information Management System
US7668730B2 (en) * 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
CA2616511C (en) * 2007-07-06 2017-11-07 Catalyst Healthcare Ltd. Medication dose administration and inventory management
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
WO2010104841A2 (en) * 2009-03-09 2010-09-16 Celgene Corporation Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
US8392219B1 (en) * 2010-05-10 2013-03-05 Mckesson Financial Holdings Limited Systems and methods for streamlined patient enrollment for one or more healthcare programs
CA2807949C (en) * 2010-08-13 2022-10-25 Intellimedicine, Inc. System and methods for the production of personalized drug products
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
US20130292294A1 (en) * 2012-05-03 2013-11-07 Brandon J. Wilson Allergy emergency kit
CN109125283A (zh) * 2013-03-14 2019-01-04 艾慕恩治疗公司 用于口服脱敏的花生制剂的制备
WO2014159609A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
KR102233251B1 (ko) * 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
TWI633891B (zh) * 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
EP3371770A4 (en) * 2015-11-04 2019-04-24 Bayer Healthcare LLC BARCODE DATABASE AND SOFTWARE UPGRADING SYSTEM
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
US20230190645A1 (en) * 2017-12-06 2023-06-22 Prollergy Corporation Composition and method for reducing allergic response

Also Published As

Publication number Publication date
US20210151155A1 (en) 2021-05-20
US20220415464A1 (en) 2022-12-29
CN114981191A (zh) 2022-08-30
CN114981191B (zh) 2025-08-15
AU2020388398A1 (en) 2022-04-21
JP2023502423A (ja) 2023-01-24
EP4061753A4 (en) 2023-12-13
EP4061753A1 (en) 2022-09-28
WO2021102186A1 (en) 2021-05-27
CA3162233A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
Devoe et al. Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta‐analysis
MX2025007468A (es) Composiciones y metodos para el manejo de trastornos
MX2019003148A (es) Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados.
BR112015023888A2 (pt) sistema configurado para monitorar o uso de um dispositivo de aplicação de medicamento respiratório; método para monitorar o uso de um dispositivo de aplicação de medicamento respiratório com um sistema de monitoramento; e sistema configurado para monitorar o uso de meios de aplicação de medicamento a uma via aérea de um indivíduo
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
BR112016006188A2 (pt) método de tratamento com um protocolo de fármaco e um sistema com uma base de dados relacional acoplado a um ou mais dispositivos eletrônicos ; sistema para a gestão de um tratamento medicamentoso pela administração de um fármaco a um paciente e método de gestão de um tratamento com drogas usando um sistema de informação com uma base de dados relacional.
Jam et al. Nursing workload and compliance with non‐pharmacological measures to prevent ventilator‐associated pneumonia: a multicentre study
BR112022009664A2 (pt) Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos
BR112015007782A2 (pt) laquinimod para reduzir danos talâmicos na esclerose múltipla
BR112016028446A2 (pt) inibidor de complemento de ornithodoros moubata para uso no tratamento de doenças mediadas por complemento em pacientes com polimorfismo de c5
Harada et al. Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials
CL2017001859A1 (es) Inhalador de polvo seco que comprende propionato de fluticasona y xinafosfato de salmeterol
BR112015025252A2 (pt) métodos e composições usando 4-amino-2-(2,6-dioxo-piperidina-3-il)-isoindolina-1,3-diona para tratamento e gestão de cânceres de sistema nervoso central
Zhou et al. Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis
BR112018076512A2 (pt) método para gerenciar eventos adversos em populações de pacientes que requerem transfusão
Pritchard et al. The cost‐effectiveness of patient‐controlled analgesia vs. standard care in patients presenting to the Emergency Department in pain, who are subsequently admitted to hospital
Ziaeefar et al. Evaluation of elderly's integrated healthcare components in primary healthcare centers of Tehran, Iran
Hoffelt et al. Assessment and management of chronic pain in patients with depression and anxiety
Discepola et al. Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review
Guinguis et al. Is cannabidiol an effective treatment for schizophrenia
Clauw et al. Managing chronic pain with nonopioid analgesics: a multidisciplinary consult
Reviani et al. The Effect of Lavender Aromatherapy on Reducing Afterpain in Postpartum Mothers in Purwakarta Regency, Indonesia
Kurniawati et al. Kesiapsiagaan ASEGANA (Anak Sekolah Tanggap Bencana) terhadap Bencana Gempa Bumi pada Siswa di SD Pelita Bangsa Surabaya
Amir Challenges and Solutions Towards Antimicrobial Stewardship Implementation

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]